225 related articles for article (PubMed ID: 12439644)
1. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women.
Macho-Azcarate T; Marti A; González A; Martinez JA; Ibañez J
Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1434-41. PubMed ID: 12439644
[TBL] [Abstract][Full Text] [Related]
2. Basal fat oxidation and after a peak oxygen consumption test in obese women with a beta2 adrenoceptor gene polymorphism.
Macho-Azcarate T; Marti A; Calabuig J; Martinez JA
J Nutr Biochem; 2003 May; 14(5):275-9. PubMed ID: 12832031
[TBL] [Abstract][Full Text] [Related]
3. Obesity gene variant and elite endurance performance.
Moore GE; Shuldiner AR; Zmuda JM; Ferrell RE; McCole SD; Hagberg JM
Metabolism; 2001 Dec; 50(12):1391-2. PubMed ID: 11735081
[TBL] [Abstract][Full Text] [Related]
4. A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism.
Macho-Azcárate T; Calabuig J; Martí A; Martínez JA
J Physiol Biochem; 2002 Jun; 58(2):103-8. PubMed ID: 12435085
[TBL] [Abstract][Full Text] [Related]
5. Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding.
Ukkola O; Tremblay A; Bouchard C
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1604-8. PubMed ID: 11753578
[TBL] [Abstract][Full Text] [Related]
6. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain.
González Sánchez JL; Proenza AM; Martínez Larrad MT; Ramis JM; Fernández Pérez C; Palou A; Serrano Ríos M
Clin Endocrinol (Oxf); 2003 Oct; 59(4):476-81. PubMed ID: 14510910
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women.
Rosado EL; Bressan J; Martins MF; Cecon PR; Martínez JA
Appetite; 2007 Nov; 49(3):635-43. PubMed ID: 17658197
[TBL] [Abstract][Full Text] [Related]
9. Environmental factors and beta2-adrenergic receptor polymorphism: influence on the energy expenditure and nutritional status of obese women.
Rosado EL; Bressan J; Martínez JA
Lipids; 2015 May; 50(5):459-67. PubMed ID: 25893811
[TBL] [Abstract][Full Text] [Related]
10. [Effect of diet and PPARgamma2 and beta2-adrenergic receptor genes on energy metabolism and body composition in obese women].
Rosado EL; Bressan J; Hernández JA; Martins MF; Cecon PR
Nutr Hosp; 2006; 21(3):317-31. PubMed ID: 16771114
[TBL] [Abstract][Full Text] [Related]
11. Influence of ADRB2 Gln27Glu and ADRB3 Trp64Arg polymorphisms on body weight and body composition changes after a controlled weight-loss intervention.
Szendrei B; González-Lamuño D; Amigo T; Wang G; Pitsiladis Y; Benito PJ; Gomez-Candela C; Calderón FJ; Cupeiro R;
Appl Physiol Nutr Metab; 2016 Mar; 41(3):307-14. PubMed ID: 26888112
[TBL] [Abstract][Full Text] [Related]
12. Neurovascular control during exercise in acute coronary syndrome patients with Gln27Glu polymorphism of β2-adrenergic receptor.
Ferreira-Santos L; Martinez DG; Nicolau JC; Moreira HG; Alves MJ; Pereira AC; Trombetta IC; Negrão CE; Rondon MU
PLoS One; 2017; 12(2):e0173061. PubMed ID: 28235084
[TBL] [Abstract][Full Text] [Related]
13. Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation.
Jocken JW; Blaak EE; Schiffelers S; Arner P; van Baak MA; Saris WH
Int J Obes (Lond); 2007 May; 31(5):813-9. PubMed ID: 17130852
[TBL] [Abstract][Full Text] [Related]
14. Association of the FTO and ADRB2 genes with body composition and fat distribution in obese women.
Rauhio A; Uusi-Rasi K; Nikkari ST; Kannus P; Sievänen H; Kunnas T
Maturitas; 2013 Oct; 76(2):165-71. PubMed ID: 23911093
[TBL] [Abstract][Full Text] [Related]
15. Role of β₂-adrenergic receptor polymorphisms on body weight and body composition response to energy restriction in obese women: preliminary results.
Ruiz JR; Larrarte E; Margareto J; Ares R; Labayen I
Obesity (Silver Spring); 2011 Jan; 19(1):212-5. PubMed ID: 20523301
[TBL] [Abstract][Full Text] [Related]
16. Low plasma leptin concentration and low rates of fat oxidation in weight-stable post-obese subjects.
Filozof CM; Murúa C; Sanchez MP; Brailovsky C; Perman M; Gonzalez CD; Ravussin E
Obes Res; 2000 May; 8(3):205-10. PubMed ID: 10832762
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the glutamine 27 glutamic acid polymorphism in the adrenoceptor β2 surface gene on obesity and metabolic phenotypes in Taiwan.
Hsiao TJ; Lin E
J Investig Med; 2014 Feb; 62(2):310-5. PubMed ID: 24322328
[TBL] [Abstract][Full Text] [Related]
18. [Effects of the beta2-adrenergic receptor Gln27Glu variation on changes of serum lipid and apolipoprotein ratios induced by a high-carbohydrate/low-fat diet in healthy youth].
Ou GJ; Fang DZ; Gong RR; Zhang Z; Li YH; Jiang Z; Fan M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):775-9. PubMed ID: 22332540
[TBL] [Abstract][Full Text] [Related]
19. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
20. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects.
de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R
Ann Nutr Metab; 2006; 50(4):354-60. PubMed ID: 16809903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
